View Single Post
Old 05-03-2007, 10:14 AM   #17
saleboat
Senior Member
 
saleboat's Avatar
 
Join Date: Sep 2005
Location: NYC
Posts: 250
I read the book and the story is pretty amazing. Scary that Herceptin almost didn't get out of the development phase. One of the take-aways from the book was the power of the advocacy community-- they really rallied to get as many women as possible included in the adjuvent trials, with the well-founded hunch that the drug would be a wonder.

Given the premium that these drugs are commanding, I can imagine that the business development people are all to happy to take bets now on targeted therapy-- at the time Herceptin was developed, it really was out-of-the-box thinking.

Here's a link to the book:
http://www.amazon.com/Her-2-Making-H...8212264&sr=8-1

Jen
__________________
dx 4/05 @ 34 y.o.
Stage IIIC, ER+ (90%)/PR+ (95%)/HER2+ (IHC 3+)
lumpectomy-- 2.5 cm 15+/37 nodes
(IVF in between surgery and chemo)
tx dd A/C, followed by dd Taxol & Herceptin
30 rads (or was it 35?)
Finished Herceptin on 7/24/06
Tamox
livingcured.blogspot.com

"Keep your face to the sunshine and you cannot see the shadow." -- Helen Keller
saleboat is offline   Reply With Quote